Clinical trial
A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Efficacy of ARCR Augmented With REGENETEN™ Bioinductive Implant System in Full-thickness Tears (Large or Massive) Repair Versus ARCR Alone
NCT04450342 is registered in ClinicalTrials.gov with Smith & Nephew, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Efficacy of ARCR Augmented With REGENETEN™ Bioinductive Implant System in Full-thickness Tears (Large or Massive) Repair Versus ARCR Alone
- Lead sponsor
- Smith & Nephew, Inc.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 7, 2020
- Completion date
- October 31, 2023
- Enrollment
- 119 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.